Press Release

 

Osmetech plc ('Osmetech' or the 'Company')

 

Disclosure of Significant Shareholdings

 

26 May 2009

 

Osmetech PLC ('Osmetech' or 'the Company') (AIM:OMH) announces that it was notified on 23 May 2009 that Efficacy Capital Limited (‘Efficacy’) has purchased 8,125,000 ordinary 0.1p shares in the Company.

Efficacy’s total interest in Osmetech shares of is now 299,582,742 shares representing 33.60% or the current issued share capital. Efficacy’s interest is held as follows:

 

Registered Owner

Number of ordinary shares

% if issued share capital

Efficacy Biotech Master Fund

296,612,742

33.27%

FMG Special Opportunity Fund

 2,970,000

0.33%

Total

299,582,742

33.60%

 

The total number of issued ordinary 0.1p shares is 891,607,157. Osmetech does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in Osmetech is 891,607,157.  
 
For further information:
 

Osmetech plc:

+44 (0) 20 7849 6027

James White, Chief Executive

 

David Sandilands, Finance Director

 

 

 

Madano Partnership:

+44 (0) 207 593 4000

Mark Way

 

 

 

Canaccord Adams Limited:

+44 (0) 20 7050 6500

Robert Finlay

 

Henry Fitzgerald-O'Connor